Congjuan Luo

965 total citations
29 papers, 705 citations indexed

About

Congjuan Luo is a scholar working on Nephrology, Molecular Biology and Surgery. According to data from OpenAlex, Congjuan Luo has authored 29 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 11 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Congjuan Luo's work include Acute Kidney Injury Research (6 papers), Mesenchymal stem cell research (5 papers) and Gout, Hyperuricemia, Uric Acid (5 papers). Congjuan Luo is often cited by papers focused on Acute Kidney Injury Research (6 papers), Mesenchymal stem cell research (5 papers) and Gout, Hyperuricemia, Uric Acid (5 papers). Congjuan Luo collaborates with scholars based in China and Germany. Congjuan Luo's co-authors include Li Zhang, Xiangmei Chen, Bo Fu, Yan Xu, Shaoyuan Cui, Ruixia Ma, Diangeng Li, Xuemei Liu, Liqiu Liu and Huifang Wang and has published in prestigious journals such as British Journal Of Nutrition, Frontiers in Pharmacology and Frontiers in Physiology.

In The Last Decade

Congjuan Luo

26 papers receiving 697 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Congjuan Luo China 14 259 235 213 179 127 29 705
An-Hang Yang Taiwan 13 173 0.7× 168 0.7× 148 0.7× 126 0.7× 59 0.5× 30 694
Irene de Lourdes Noronha Brazil 11 305 1.2× 129 0.5× 150 0.7× 107 0.6× 73 0.6× 26 704
Lichuan Yang China 18 363 1.4× 194 0.8× 151 0.7× 77 0.4× 78 0.6× 40 776
Sung Jig Lim South Korea 13 198 0.8× 207 0.9× 177 0.8× 71 0.4× 92 0.7× 26 709
Rujuan Xie China 16 140 0.5× 194 0.8× 96 0.5× 71 0.4× 209 1.6× 33 742
Manuel Alfredo Podestà Italy 19 538 2.1× 235 1.0× 199 0.9× 84 0.5× 218 1.7× 50 1.1k
Yuan‐Han Qin China 21 275 1.1× 372 1.6× 71 0.3× 71 0.4× 97 0.8× 54 943
Jianguang Gong China 11 183 0.7× 306 1.3× 93 0.4× 61 0.3× 58 0.5× 29 601
Brooke M. Huuskes Australia 10 111 0.4× 495 2.1× 145 0.7× 104 0.6× 91 0.7× 19 852
Shinsuke Hanatani Japan 19 141 0.5× 325 1.4× 98 0.5× 52 0.3× 49 0.4× 81 902

Countries citing papers authored by Congjuan Luo

Since Specialization
Citations

This map shows the geographic impact of Congjuan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congjuan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congjuan Luo more than expected).

Fields of papers citing papers by Congjuan Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congjuan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congjuan Luo. The network helps show where Congjuan Luo may publish in the future.

Co-authorship network of co-authors of Congjuan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Congjuan Luo. A scholar is included among the top collaborators of Congjuan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congjuan Luo. Congjuan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Lin, Feng Luo, Nan Yuan, et al.. (2025). Research progress of ferroptosis in acute kidney injury. Frontiers in Cell and Developmental Biology. 13. 1614156–1614156.
4.
Chen, Guan, Chenyu Li, Xuefei Shen, et al.. (2023). Hexarelin alleviates apoptosis on ischemic acute kidney injury via MDM2/p53 pathway. European journal of medical research. 28(1). 344–344. 4 indexed citations
5.
Wang, Hui‐Fang, et al.. (2023). Elevated serum uric acid is associated with renal arteriolopathy and predict poor outcome in patients with lupus nephritis. Clinical and Experimental Rheumatology. 42(1). 30–38. 4 indexed citations
6.
Li, Xunliang, Hong Luan, Hui Zhang, et al.. (2021). Associations between early thiamine administration and clinical outcomes in critically ill patients with acute kidney injury. British Journal Of Nutrition. 128(2). 183–191. 5 indexed citations
7.
Xu, Lingyu, Chenyu Li, Long Zhao, et al.. (2020). Acute kidney injury after nephrectomy: a new nomogram to predict postoperative renal function. BMC Nephrology. 21(1). 181–181. 17 indexed citations
8.
Luo, Feng, Wei Jiang, Yan Xu, et al.. (2020). The Mechanisms Involved in Mesenchymal Stem Cell Alleviation of Sepsis-Induced Acute Lung Injury in Mice: A Pilot Study. Current Therapeutic Research. 93. 100593–100593. 10 indexed citations
9.
Li, Guozheng, Guan Chen, Lingyu Xu, et al.. (2020). Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice. Frontiers in Pharmacology. 11. 584942–584942. 33 indexed citations
10.
Luo, Congjuan, Feng Luo, Wei Jiang, et al.. (2019). Protective effects of resveratrol on acute kidney injury in rats with sepsis. Biomedical Papers. 164(1). 49–56. 24 indexed citations
11.
Zhao, Long, Jisheng Zhang, Chenyu Li, et al.. (2019). Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts. Frontiers in Physiology. 10. 464–464. 8 indexed citations
12.
Li, Chenyu, Lingyu Xu, Guan Chen, et al.. (2019). Malnutrition screening and acute kidney injury in hospitalised patients: a retrospective study over a 5-year period from China. British Journal Of Nutrition. 123(3). 337–346. 36 indexed citations
13.
Dong, Hui, Yue Zhang, Yan Xu, et al.. (2019). Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-β1. Acta Biochimica et Biophysica Sinica. 51(6). 644–651. 18 indexed citations
14.
Liu, Xuemei, Huifang Wang, Ruixia Ma, et al.. (2018). The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3–5. Clinical and Experimental Nephrology. 23(3). 362–370. 26 indexed citations
15.
Li, Xiuzhen, et al.. (2018). Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation. Immunologic Research. 66(4). 521–527. 29 indexed citations
16.
Li, Chenyu, Long Zhao, Yanfei Wang, et al.. (2018). Cysteine‐rich protein 61, a specific ultra‐early biomarker in kidney ischemia/reperfusion injury. Nephrology. 24(8). 798–805. 15 indexed citations
17.
Luo, Congjuan, Feng Luo, Li Zhang, et al.. (2016). Knockout of interleukin-17A protects against sepsis-associated acute kidney injury. Annals of Intensive Care. 6(1). 56–56. 38 indexed citations
18.
Zhang, Li, Bo Fu, Jianrong Zhang, et al.. (2014). Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Research & Therapy. 5(3). 80–80. 132 indexed citations
19.
Zhang, Li, Kanghua Li, Xiangfei Liu, et al.. (2013). Repeated Systemic Administration of Human Adipose-Derived Stem Cells Attenuates Overt Diabetic Nephropathy in Rats. Stem Cells and Development. 22(23). 3074–3086. 60 indexed citations
20.
Luo, Congjuan, Fujian Zhang, Li Zhang, et al.. (2013). Mesenchymal Stem Cells Ameliorate Sepsis-associated Acute Kidney Injury in Mice. Shock. 41(2). 123–129. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026